Related references
Note: Only part of the references are listed.Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
Maria A. Tikhonova et al.
FRONTIERS IN NEUROSCIENCE (2022)
The β-Secretase BACE1 in Alzheimer's Disease
Harald Hampel et al.
BIOLOGICAL PSYCHIATRY (2021)
Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite
Veronica Serafin et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease
Sanjay Arora et al.
MOLECULAR PHARMACEUTICS (2021)
Chitosan nanoparticles to enhance nasal absorption and brain targeting of sitagliptin to treat Alzheimer's disease
Barnabas Wilson et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
DEVELOPMENT OF RIVASTIGMINE LOADED SELF ASSEMBLED NANOSTRUCTURES OF NONIONIC SURFACTANTS FOR BRAIN DELIVERY
SARASWATHI T. S. et al.
International Journal of Applied Pharmaceutics (2021)
Nanotechnology-based drug delivery for central nervous system disorders
Thuy Trang Nguyen et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives
Kehinde D. Fasae et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2021)
Nanomedicine: A Promising Way to Manage Alzheimer's Disease
Nazeer Hussain Khan et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Green Synthesis of Zinc Oxide (ZnO) Nanoparticles Using Aqueous Fruit Extracts of Myristica fragrans: Their Characterizations and Biological and Environmental Applications
Shah Faisal et al.
ACS OMEGA (2021)
Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer's disease
Pratik Kulkarni et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
2021 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2021)
MRI-traceable theranostic nanoparticles for targeted cancer treatment
Tareq Anani et al.
THERANOSTICS (2021)
Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer's Disease Model
Natalia dos Santos Tramontin et al.
MOLECULAR NEUROBIOLOGY (2020)
Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: Novel theranostic agents for Alzheimer's disease
Jing Cai et al.
DYES AND PIGMENTS (2020)
The prevalence of Alzheimer's disease in the Chinese Han population: a meta-analysis
Xingxing Zhao et al.
NEUROLOGICAL RESEARCH (2020)
Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer's Disease
Shen Luo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer’s Disease
Bo Liu et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Memantine nanoemulsion: a new approach to treat Alzheimer's disease
Atinderpal Kaur et al.
JOURNAL OF MICROENCAPSULATION (2020)
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
Julia Companys-Alemany et al.
PHARMACEUTICS (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin
Amnon C. Sintov
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-co-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer's Disease
Li Zhang et al.
MOLECULAR PHARMACEUTICS (2020)
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease
Ilaria Arduino et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis
Lei Cui et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Current and Future Treatments in Alzheimer Disease: An Update
Konstantina G. Yiannopoulou et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2020)
The Role of NMDA Receptors in Alzheimer's Disease
Jinping Liu et al.
FRONTIERS IN NEUROSCIENCE (2019)
A walk through tau therapeutic strategies
Santosh Jadhav et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer's Disease in a Rat Animal Model: Involvement of STIM Proteins
Mehdi Sanati et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Preparation and characterization of curcumin-loaded polymeric nanomicelles to interference with amyloidogenesis through glycation method
Zeinab Mirzaie et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2019)
Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice
Seong Gak Jeon et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection
Ester Aso et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Nusinersen in later-onset spinalmuscular atrophy Long-term results from the phase 1/2 studies
Basil T. Darras et al.
NEUROLOGY (2019)
Antisense Oligonucleotide Therapies for Neurodegenerative Diseases
C. Frank Bennett et al.
Annual Review of Neuroscience (2019)
Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders
Hanie Yavarpour-Bali et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence
Soroor Sadegh Malvajerd et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Cholinesterase inhibitors as Alzheimer's therapeutics
Kamlesh Sharma
MOLECULAR MEDICINE REPORTS (2019)
Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice
Avinash Gothwal et al.
BIOCONJUGATE CHEMISTRY (2019)
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study
Kumar B. Rajan et al.
ALZHEIMERS & DEMENTIA (2019)
New approaches for the treatment of Alzheimer's disease
Paul V. Fish et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier
Ka Hong Wong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain
Rahul P. Patil et al.
JOURNAL OF LIPOSOME RESEARCH (2019)
A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid beta aggregation in Alzheimer's disease
Xinlong Huo et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
Gene Therapy for Neurodegenerative Diseases
Vivek Sudhakar et al.
NEUROTHERAPEUTICS (2019)
Nanoparticle Assisted Regulation of Nucleation Pathway of Amyloid Tetramer and Inhibition of Their Fibrillation Kinetics
Subrata Mondal et al.
ACS APPLIED BIO MATERIALS (2019)
Template-Mediated Detoxification of Low-Molecular-Weight Amyloid Oligomers and Regulation of Their Nucleation Pathway
Subrata Mondal et al.
ACS APPLIED BIO MATERIALS (2019)
Risk factors for Alzheimer's disease
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2019)
Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease
Krithika Muthukumaran et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease
Qingqing Meng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments
Yacoubou Abdoul Razak Mahaman et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
Jaume Folch et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Nose-to-brain delivery of insulin enhanced by a nanogel carrier
Pasquale Picone et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery
Antonietta Vilella et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2018)
Design and Efficacy of Nanogels Formulations for Intranasal Administration
Blessing A. Aderibigbe et al.
MOLECULES (2018)
Curcumin-loaded polymeric nanoparticles for neuro-protection in neonatal rats with hypoxic-ischemic encephalopathy
Andrea Joseph et al.
NANO RESEARCH (2018)
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
Dario Carradori et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences
Roxana Braga de Andrade Teles et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Panax ginseng as an adjuvant treatment for Alzheimer's disease
Hyeon-Joong Kim et al.
JOURNAL OF GINSENG RESEARCH (2018)
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization
Elena Sanchez-Lopez et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice
Vincenzo Sorrenti et al.
FRONTIERS IN PHARMACOLOGY (2018)
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Judite R. M. Coimbra et al.
FRONTIERS IN CHEMISTRY (2018)
The Effects of Acorus calamus L. in Preventing Memory Loss, Anxiety, and Oxidative Stress on Lipopolysaccharide-induced Neuroinflammation Rat Models
Ebrahim Esfandiari et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2018)
An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine
Rita Khoury et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer's disease in Japan
William Montgomery et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2018)
Brain biometals and Alzheimer's disease - boon or bane?
Atish Prakash et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety
Beverly A. Rzigalinski et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
Trends of mortality from Alzheimer's disease in the European Union, 1994-2013
H. Niu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Memantine reduces the production of amyloid-β peptides through modulation of amyloid precursor protein trafficking
Kaori Ito et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease
Lina Clara Gayoso e Ibiapina Moreno et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development
Angelica Gonzalez-Maciel et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Lindsay A. Becker et al.
NATURE (2017)
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Daniel R. Scoles et al.
NATURE (2017)
Oligonucleotide therapies for disorders of the nervous system
Olga Khorkova et al.
NATURE BIOTECHNOLOGY (2017)
Differential Molecular Targets for Neuroprotective Effect of Chlorogenic Acid and its Related Compounds Against Glutamate Induced Excitotoxicity and Oxidative Stress in Rat Cortical Neurons
Olfa Rebai et al.
NEUROCHEMICAL RESEARCH (2017)
Prevalence and incidence of Alzheimer's disease in Europe: A meta -analysis
H. Niu et al.
NEUROLOGIA (2017)
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease
Thomas N. Chase et al.
NEUROTHERAPEUTICS (2017)
Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?
Melania Maria Serafini et al.
PHARMACOLOGICAL RESEARCH (2017)
Neuroprotective Effects of Aged Garlic Extract on Cognitive Dysfunction and Neuroinflammation Induced by β-Amyloid in Rats
Nutchareeporn Nillert et al.
NUTRIENTS (2017)
MiR-124-3p attenuates hyperphosphorylation of tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells
Qingmei Kang et al.
ONCOTARGET (2017)
Two decades of new drug discovery and development for Alzheimer's disease
Zhidong Liu et al.
RSC ADVANCES (2017)
Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons
Yousuf O. Ali et al.
SCIENTIFIC REPORTS (2017)
Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study
Annabel Price et al.
BMJ OPEN (2017)
Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease
Ling Zhu et al.
ADVANCED MATERIALS (2017)
Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease
Kaustubh S. Chaudhari et al.
ANNALS OF NEUROSCIENCES (2017)
Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease
T. Foster et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Caroline Van Cauwenberghe et al.
GENETICS IN MEDICINE (2016)
Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer's Disease
Hyek Jin Kwon et al.
ACS NANO (2016)
The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis
Kirsten M. Fiest et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Alzheimer's Disease: Targeting the Cholinergic System
Talita H. Ferreira-Vieira et al.
CURRENT NEUROPHARMACOLOGY (2016)
Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays
Chih-Hsin Lin et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Oxidative challenge in Alzheimer's disease: state of knowledge and future needs
Carlo Cervellati et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Current and novel therapeutic molecules and targets in Alzheimer's disease
Ashwini Kumar et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)
Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model
Sanaa M. R. Wahba et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study
Gaurav Kumar et al.
MEDICAL HYPOTHESES (2016)
Urtica dioica modulates hippocampal insulin signaling and recognition memory deficit in streptozotocin induced diabetic mice
Sita Sharan Patel et al.
METABOLIC BRAIN DISEASE (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Acetylcholine esterase inhibitors and melanin synthesis inhibitors from Salvia officinalis
Amal Sallam et al.
PHYTOMEDICINE (2016)
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
Carina Wattmo et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Nanotheranostics: Congo Red/Rutin-MNPs with Enhanced Magnetic Resonance Imaging and H2O2-Responsive Therapy of Alzheimer's Disease in APPswe/PS1dE9 Transgenic Mice
Bingbing Hu et al.
ADVANCED MATERIALS (2015)
Slowing the progression of Alzheimer's disease; what works?
Lucy Nelson et al.
AGEING RESEARCH REVIEWS (2015)
Selenium compounds as therapeutic agents in cancer
Aristi P. Fernandes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice
Takuya Ohba et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2015)
Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer's disease
Min Liu et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease
Xu Liu et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity
Yosra S. R. Elnaggar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - Impact on bioavailability
Stephanie Hagl et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
A review on Alzheimer's disease pathophysiology and its management: an update
Anil Kumar et al.
PHARMACOLOGICAL REPORTS (2015)
Carbon Nanotropes: A Contemporary Paradigm in Drug Delivery
Avinash C. Tripathi et al.
MATERIALS (2015)
β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease
Xiaojuan Sun et al.
FRONTIERS IN PHARMACOLOGY (2015)
Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America
Claire Takizawa et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice
Barbara Budzynska et al.
PSYCHOPHARMACOLOGY (2015)
Future directions in Alzheimer's disease from risk factors to prevention
Bushra Imtiaz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Christiane Reitz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
Robert Vassar
ALZHEIMERS RESEARCH & THERAPY (2014)
Structure, Function, and Pharmacology of NMDA Receptor Channels
V. Vyklicky et al.
PHYSIOLOGICAL RESEARCH (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
A review on cholinesterase inhibitors for Alzheimer's disease
Preet Anand et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Novel BACE1 inhibitors with a non-acidic heterocycle at the P1′ position
Kenji Suzuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Sandra Rocha
CURRENT PHARMACEUTICAL DESIGN (2013)
Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A beta), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy
Anchalee Prasansuklab et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain
Marcin Ozarowski et al.
FITOTERAPIA (2013)
Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
Jian-Zhi Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis
Kit Yee Chan et al.
LANCET (2013)
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease
Yu-Jhen Huang et al.
CURRENT NEUROPHARMACOLOGY (2012)
Neuromodulatory Propensity of Bacopa monnieri Leaf Extract Against 3-Nitropropionic Acid-Induced Oxidative Stress: In Vitro and In Vivo Evidences
George K. Shinomol et al.
NEUROTOXICITY RESEARCH (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Spyridon Mourtas et al.
BIOMATERIALS (2011)
The Aged Garlic Extract (AGE) and One of its Active Ingredients S-Allyl-L-Cysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD)
B. Ray et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Natural products as a source of Alzheimer's drug leads
Philip Williams et al.
NATURAL PRODUCT REPORTS (2011)
Alzheimer and his disease: a brief history
Gabriele Cipriani et al.
NEUROLOGICAL SCIENCES (2011)
Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models
Anat Frydman-Marom et al.
PLOS ONE (2011)
Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein Fibrillation
Celia Cabaleiro-Lago et al.
ACS CHEMICAL NEUROSCIENCE (2010)
In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles
Wolfgang Haertig et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Galantamine for Alzheimer's disease
David Prvulovic et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy
Alfred Maelicke et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine
Barnabas Wilson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Effect of Evolvulus alsinoides Linn. on Learning Behavior and Memory Enhancement Activity in Rodents
Alok Nahata et al.
PHYTOTHERAPY RESEARCH (2010)
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid
Jae Woong Lee et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-β fibrils detection and removal by a magnetic field
Hadas Skaat et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Synthesis and Characterization of Poly(ethylene glycol)-Glutathione Conjugate Self-Assembled Nanoparticles for Antioxidant Delivery
Sharlene R. Williams et al.
BIOMACROMOLECULES (2009)
The binding of pullulan modified cholesteryl nanogels to Aβ oligomers and their suppression of cytotoxicity
Sebastien Boridy et al.
BIOMATERIALS (2009)
Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress
Xiaowei Lu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain
Syed Waseem Bihaqi et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Nanoparticle-chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
Gang Liu et al.
NEUROSCIENCE LETTERS (2009)
Consumption of Grape Seed Extract Prevents Amyloid-beta Deposition and Attenuates Inflammation in Brain of an Alzheimer's Disease Mouse
Yan-Jiang Wang et al.
NEUROTOXICITY RESEARCH (2009)
Omega-3 fatty acids and dementia
Greg M. Cole et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Polysaccharides-based nanoparticles as drug delivery systems
Zonghua Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
The effect of curcumin (turmeric) on Alzheimer's disease: An overview
Shrikant Mishra et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2008)
Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid β self-assembly
Jin-sil Choi et al.
CHEMICAL COMMUNICATIONS (2008)
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
Barnabas Wilson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation
So-Young Park et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
Aynun N. Begum et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles
Celia Cabaleiro-Lago et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Gold Nanoparticles and Microwave Irradiation Inhibit Beta-Amyloid Amyloidogenesis
Eyleen Araya et al.
NANOSCALE RESEARCH LETTERS (2008)
Effect of glabridin from Glycyrrhiza glabra on learning and memory in mice
Yong-Ming Cui et al.
PLANTA MEDICA (2008)
Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy
Edward K. Agyare et al.
PHARMACEUTICAL RESEARCH (2008)
Galantamine in Alzheimer’s disease
George Razay et al.
Expert Review of Neurotherapeutics (2007)
Aqueous and hydroalcoholic extracts of Black Maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice
Julio Rubio et al.
FOOD AND CHEMICAL TOXICOLOGY (2007)
Alzheimer's Disease: Clinical features, pathogenesis, and treatment
Kaye L. Rathmann et al.
ANNALS OF PHARMACOTHERAPY (2007)
Attenuation of β-amyloid-induced toxicity by sialic-acid-conjugated dendrimers:: Role of sialic acid attachment
Dhara A. Patel et al.
BRAIN RESEARCH (2007)
Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice
Gunjan Saxena et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms
Song Li et al.
LIFE SCIENCES (2007)
PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro
Ashwini S. Pai et al.
PEPTIDES (2006)
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
Gang Liu et al.
NEUROSCIENCE LETTERS (2006)
Cholinergic basis of memory-strengthening effect of Foeniculum vulgare Linn.
Hanumanthachar Joshi et al.
JOURNAL OF MEDICINAL FOOD (2006)
Molecular interactions of dendrimers with amyloid peptides: pH dependence
B. Klajnert et al.
BIOMACROMOLECULES (2006)
Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain
Amar Jyoti et al.
NEUROTOXICOLOGY (2006)
Nardostachys jatamansi improves learning and memory in mice
Hanumanthachar Joshi et al.
JOURNAL OF MEDICINAL FOOD (2006)
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
ZR Cui et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Protective properties of melatonin-loaded nanoparticles against lipid peroxidation
SR Schaffazick et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Acetylcholinesterase and its inhibition in Alzheimer disease
RM Lane et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity
MH Oh et al.
PHYTOMEDICINE (2004)
Cholinesterase inhibitors for the treatment of Alzheimer's disease: Getting on and staying on
GT Grossberg
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2003)
The role of acetylicholinesterase in the pathogenesis of Alzheimer's disease
TM Rees et al.
DRUGS OF TODAY (2003)
Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease - Epidemiology and management
S Gauthier
DRUGS & AGING (2001)
Galantamine - A review of its use in Alzheimer's disease
LJ Scott et al.
DRUGS (2000)
Donepezil - A review of its use in Alzheimer's disease
M Dooley et al.
DRUGS & AGING (2000)
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
M Farlow et al.
EUROPEAN NEUROLOGY (2000)
Share Paper
